Skip to main content

Table 2 Bivariate analysis of HCV Notifications and Demographic Risks in South Australia 2010–2016

From: RETRACTED ARTICLE: The distribution and socioeconomic burden of Hepatitis C virus in South Australia: a cross-sectional study 2010–2016

 

Rate ratio

(95%CI)

Rate difference (95%CI)

p-Value*

Non-Employment

 Indigenous Australian

5.04 (1.25–20.33)

0.14 (0.07–0.21)

0.007

 Female

1.14 (1.00–1.29)

0.05 (0.00–0.09)

0.048

 Australian origina

1.11 (1.04–1.17)

0.08 (0.03–0.12)

< 0.001

IDU previous 24 months

 Indigenous Australian

3.53 (2.32–5.35)

0.13 (0.10–0.17)

< 0.001

 Australian origin

1.58 (1.49–1.67)

0.34 (0.31–0.37)

< 0.001

 Male

1.45 (1.36–1.55)

0.26 (0.22–0.31)

< 0.001

Injecting Drug Use

 Indigenous Australian

4.93 (2.54–9.57)

0.13 (0.09–0.16)

< 0.001

 Australian origin

2.03 (1.87–2.22)

0.47 (0.42–0.51)

< 0.001

 Male

1.14 (1.06–1.22)

0.08 (0.04–0.12)

< 0.001

Prison Services contact

 Indigenous Australian

3.93 (2.57–6.04)

0.21 (0.14–0.28)

< 0.001

 Australian origin

1.52 (1.44–1.61)

0.33 (0.29–0.36)

< 0.001

 Male

1.45 (1.36–1.55)

0.26 (0.22–0.31)

< 0.001

Tattoo

 Male

1.21 (1.12–1.31)

0.13 (0.08–0.18)

< 0.001

 Australian origin

1.43 (1.34–1.53)

0.27 (0.22–0.31)

< 0.001

Household contact

 Female

1.66 (1.42–1.94)

0.21 (0.14–0.29)

< 0.001

 Origin outside Australia

1.22 (1.13–1.31)

0.15 (0.09–0.21)

< 0.001

Healthcare related infection

 Origin outside Australia

2.23 (1.86–2.66)

0.31 (0.22–0.40)

< 0.001

 Female

1.48 (1.23–1.78)

0.16 (0.07–0.25)

< 0.001

Blood products (outside Australia)

 Female

1.37 (1.04–1.83)

0.13 (− 0.00–0.26)

0.045

  1. IDU Injecting Drug Use, HCW Health Care Worker, HCV Hepatitis C virus
  2. *Tested using chi square
  3. aAustralian origin includes Aboriginal and Torres Strait Islander people